Incidence of recurrent tuberculosis among 4041 patients being treated for <i>Mycobacterium tuberculosis</i> infections.

<p>The incidence peaked within 1 to 3 years after treatment complement and gradually declined from trend analysis.</p

Flow diagram for the enrollment of study participants in the nested case-control study.

<p>After excluding patients with antecedent TB prior to 1998, HIV infection and those less than 18 years of age, the numbers of nested cohort, case and control were 4041, 152 and 608, respectively.</p

Logistic regression analysis of predictors for tuberculosis recurrence.

<p>^&Immuno-compromised diseases included liver cirrhosis, end-stage renal disease, kidney transplant, and connective tissue disease</p><p>Logistic regression analysis of predictors for tuberculosis recurrence.</p

Time to tuberculosis recurrence by year since follow-up.

<p>Time to tuberculosis recurrence by year since follow-up.</p

Characteristics of control and case groups.

<p>^<b>-</b><b>Without recurrence</b></p><p>^<b>+</b><b>With recurrence</b></p><p>*Fisher’s exact test for comparison of nominal variables.</p><p>^&Immuno-compromised diseases included liver cirrhosis, end-stage renal disease, kidney transplant and connective tissue disease.</p><p>Characteristics of control and case groups.</p

Site of tuberculosis (TB) involvement among patients with and without TB recurrence.

<p>^<b>-</b><b>Without recurrence</b></p><p>^<b>+</b><b>With recurrence</b></p><p>Site of tuberculosis (TB) involvement among patients with and without TB recurrence.</p